IPIX Innovation Pharmaceuticals Inc (PK)

-0.0015 (-11.11%)
Sep 29 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 1,569,975
Bid Price 0.011
Ask Price 0.013
News -
Day High 0.0135


52 Week Range


Day Low 0.0111
Company Name Stock Ticker Symbol Market Type
Innovation Pharmaceuticals Inc (PK) IPIX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0015 -11.11% 0.012 16:03:48
Open Price Low Price High Price Close Price Prev Close
0.0135 0.0111 0.0135 0.012 0.0135
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
85 1,569,975 $ 0.012205 $ 19,161 - 0.0101 - 0.043
Last Trade Time Type Quantity Stock Price Currency
15:58:46 23,685 $ 0.012 USD

Innovation Pharmaceuticals Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.86M 514.01M 342.36M 18k -7.04M -0.01 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Innovation Pharmaceuticals (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No IPIX Message Board. Create One! See More Posts on IPIX Message Board See More Message Board Posts

Historical IPIX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.016150.0180.01110.013506308,875-0.00415-25.7%
1 Month0.014850.0180.01110.0152298233,565-0.00285-19.19%
3 Months0.0180.020.01010.0159228276,186-0.006-33.33%
6 Months0.02250.0230.01010.0173514267,401-0.0105-46.67%
1 Year0.03710.0430.01010.0206598463,410-0.0251-67.65%
3 Years0.20020.540.01010.16204171,241,763-0.1882-94.01%
5 Years0.210.650.01010.18028321,294,892-0.198-94.29%

Innovation Pharmaceuticals (PK) Description

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now